Company / Gross Margin
Viatris Gross Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
35.1%
FY2025
5-year range
31.8% / 41.7%
FY2021-FY2025
Trend
-8.1%
vs FY2024
Sector context
#24 of 28
Health Care
What the data says
Viatris's gross margin of 35.1% is lower than 86% of companies in the Health Care sector (FY2025). Gross Margin has fluctuated over the past 8 years, ranging from 31.8% in FY2022 to 41.7% in FY2023.
Based on SEC 10-K filings.
35.1% in FY2025 with a 5-year CAGR of +0.1%.
Declined from 41.7% to 35.1% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +3.3pp
- 5-Year Change
- +0.1pp
- 10-Year Change
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 28This company 35.1% Sector average 60.3%
▼
-41.9% below sector average
Key checks
Key Insights
- In FY2025, gross margin decreased 8.1% year-over-year.
- Currently 25.2pp below the Health Care sector average.
- Peak gross margin was recorded in FY2023.
- Lowest gross margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 35.1% | -8.1% |
| FY2024 | 38.1% | -8.6% |
| FY2023 | 41.7% | +31.3% |
| FY2022 | 31.8% | -6.2% |
| FY2021 | 33.9% | -3.2% |
| FY2020 | 35.0% | +3.3% |
| FY2019 | 33.9% | -3.2% |
| FY2018 | 35.0% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026